NasdaqGM:RPD
NasdaqGM:RPDSoftware

Rapid7 (RPD): Valuation Check After New HITRUST Compliance Partnership and Cybersecurity Risk Outlook

Rapid7 (RPD) just deepened its compliance and security story by teaming up with HITRUST to automate evidence collection and continuous control validation, while also publishing 2026 threat predictions that lean heavily into insider risk and geopolitical cyber fallout. See our latest analysis for Rapid7. Despite these moves to sharpen its compliance and threat story, Rapid7’s recent performance is mixed, with a strong 1 month share price return of 16.5% from $16.35 but a much weaker year to...
NYSE:TNC
NYSE:TNCMachinery

Did Tennant’s (TNC) Soft Quarter and Higher Guidance Just Reframe Its Long-Term Playbook?

Earlier this month, Tennant reported quarterly revenue down 4% year on year, missing analyst expectations on both sales and earnings, while still lifting its full-year guidance amid a complex market backdrop. This unusual mix of a weak quarter and higher guidance highlights management’s confidence in Tennant’s longer-term plan despite near-term operational headwinds. We’ll now examine how Tennant’s raised full-year guidance, despite the quarterly earnings miss, may reshape its existing...
NYSE:ALG
NYSE:ALGMachinery

Evaluating Alamo Group’s Valuation After Its Recent Share Price Rebound

Why Alamo Group Stock Is Back on Investors Radar Alamo Group (ALG) has quietly delivered steady operational growth, and its recent share move is drawing fresh attention from investors looking for durable industrial names with dependable fundamentals and room for re rating. See our latest analysis for Alamo Group. That recent pop in the share price, with a 7 day share price return of 7.58% and 1 month share price return of 9.17%, is mostly a bounce within a still negative 1 year total...
NYSE:FLR
NYSE:FLRConstruction

Fluor (FLR): Valuation Check After New Highland Valley Copper Win and LNG Canada Train 2 Milestone

Fluor (FLR) just landed a major win in Canada, securing Teck Resources’ Highland Valley Copper Mine life extension project while also wrapping up Train 2 of the LNG Canada build, and both deals sharpen the stock’s long term project backlog story. See our latest analysis for Fluor. Even with these contract wins, Fluor’s $43.6 share price is still digesting earlier disappointment, with a negative year to date share price return but a solid five year total shareholder return suggesting longer...
NasdaqGS:TPG
NasdaqGS:TPGCapital Markets

TPG (TPG) Is Up 8.4% After Beating Revenue Forecasts And Closing Oversubscribed Credit Fund III

Earlier this month, TPG Inc. reported 12% year-on-year revenue growth that surpassed analyst expectations and closed its AG Credit Solutions Fund III with US$6.20 billion in capital commitments, significantly above its original target. The combination of stronger-than-expected top-line performance and outsized private credit fundraising signals firm momentum in TPG’s fee-generating platform and investor demand for its credit strategies. We’ll now examine how this stronger-than-expected...
NYSE:CWK
NYSE:CWKReal Estate

The Bull Case For Cushman & Wakefield (CWK) Could Change Following Its New Data Center Focus – Learn Why

In early December 2025, Cushman & Wakefield used its Investor Day to outline a refreshed plan to grow leasing, capital markets and higher-value services, while also highlighting data centers as a priority focus area. This sharper emphasis on scaling recurring, higher-margin service lines and data center capabilities signals a push to diversify beyond traditional, more cyclical commercial real estate revenue streams. We’ll now examine how this renewed focus on higher-margin services and...
NYSE:LOB
NYSE:LOBBanks

Live Oak Bancshares (LOB): Reassessing Valuation After Financial Restatement and Investor Investigation

Live Oak Bancshares (LOB) is back in the spotlight after an investor rights firm launched a probe into its recent financial restatement tied to cash flow misclassifications and potential disclosure issues. Investors are understandably reassessing both trust and valuation. See our latest analysis for Live Oak Bancshares. The legal probe lands after a choppy stretch for the stock, with a 13.32% 30 day share price return helping claw back some ground even as the year to date share price return...
NasdaqGS:UPWK
NasdaqGS:UPWKProfessional Services

Upwork (UPWK): Reassessing Valuation After Investor Day Ambitions and New OpenAI, YouLend Partnerships

Upwork (UPWK) just turned a routine Investor Day into a small sentiment reset, outlining aggressive growth ambitions while rolling out new partnerships aimed at making its freelance marketplace more useful for both workers and businesses. See our latest analysis for Upwork. That optimism is lining up neatly with the price action, with the share price at $21.95 after a roughly 33 percent year to date share price return and a strong three year total shareholder return of about 102 percent,...
NasdaqGM:VITL
NasdaqGM:VITLFood

Assessing Vital Farms (VITL) Valuation After S&P SmallCap 600 Index Inclusion and Investor Interest Spike

Vital Farms (VITL) just got a meaningful visibility boost, joining the S&P SmallCap 600 and several related S&P indices. Investors reacted quickly, pushing the stock up about 6% on the news. See our latest analysis for Vital Farms. That index bump adds a new chapter to what has been a volatile stretch, with an 8.1% 7 day share price return and a 27.1% 90 day share price pullback, even as the three year total shareholder return sits above 120%. If this kind of momentum shift has you thinking...
NYSE:ROL
NYSE:ROLCommercial Services

Will Rollins’ (ROL) Organic Growth and Acquisitions Reset Its Long-Term Risk‑Reward Narrative?

Earlier this month, Rollins held a shareholder and analyst call to outline key initiatives for future value creation, following Q3 results that highlighted strong organic revenue growth and meaningful contributions from acquisitions. This combination of robust core performance and acquisition-driven expansion, reinforced by continued analyst optimism, suggests investors are closely watching how Rollins converts its growth levers into longer-term value. We’ll now examine how Rollins’...
NasdaqGS:PHVS
NasdaqGS:PHVSPharmaceuticals

Pharvaris (NasdaqGS:PHVS): Reassessing Valuation After RAPIDe-3 Phase 3 Success and Deucrictibant Commercial Progress

Pharvaris (NasdaqGS:PHVS) just flagged a major milestone, with its RAPIDe-3 Phase 3 data set to anchor global marketing applications for deucrictibant, potentially reshaping how hereditary angioedema (HAE) is treated worldwide. See our latest analysis for Pharvaris. Investors seem to be weighing this clinical momentum carefully, with the latest share price at $24.16 and a roughly 30% year to date share price return, while the three year total shareholder return above 220% points to powerful...
NYSE:WMS
NYSE:WMSBuilding

Reaffirmed Guidance and Surging Water-Quality Growth Might Change The Case For Investing In Advanced Drainage Systems (WMS)

In recent months, Brown Brothers Harriman highlighted Advanced Drainage Systems as a key positive contributor to its mid-cap fund after the company delivered better-than-expected sales and earnings, while Barclays reaffirmed a positive analyst stance and the firm reiterated its fiscal 2026 guidance. The business is seeing double-digit organic growth in areas such as water quality and stormwater capture solutions, even as short interest inches higher and insider selling picks up, pointing to...
NasdaqGS:EYE
NasdaqGS:EYESpecialty Retail

National Vision (EYE): Reassessing Valuation After Upgraded Guidance and New 2030 Profitability Roadmap

National Vision Holdings (EYE) just hit a fresh 52 week high after lifting its full year revenue outlook and unveiling a 2030 growth plan focused on profit expansion and multi year cost savings. See our latest analysis for National Vision Holdings. The rally around the upgraded outlook comes after a powerful run, with a year to date share price return of about 168 percent, even as the 5 year total shareholder return remains negative. This suggests momentum is rebuilding as investors reassess...
NasdaqCM:ASTH
NasdaqCM:ASTHHealthcare

Is Astrana Health’s (ASTH) Bigger Bet on Full-Risk Deals Quietly Rewriting Its Earnings Story?

Earlier this week, Needham initiated coverage of Astrana Health with a Buy rating, highlighting its focus on value-based care growth and an increased shift toward full-risk deals, while recent SEC filings showed Director Thomas Lam exercising options for 29,502 shares worth about US$99,716. The combination of upbeat analyst commentary on Astrana’s performance in value-based models and insider option exercise has drawn attention to how its risk-bearing approach might influence its long-term...